Testing effectiveness (Phase 2)Study completedNCT03812328
What this trial is testing
Study to Assess the Safety and Efficacy of SelK2 to Prevent Blood Clots in Patients Undergoing Total Knee Replacement
Who this might be right for
Venous Thromboembolism
Tetherex Pharmaceuticals Corporation 207